Hormonal contraception for female athletes presents special needs and concerns

被引:0
|
作者
Seidman, Liron [1 ]
Seidman, Daniel S. [2 ]
Constantini, Naama W. [3 ]
机构
[1] Ben Gurion Univ Negev, Soroka Univ Med Ctr, Fac Hlth Sci, Soroka Med Sch, Beer Sheva, Israel
[2] Tel Aviv Univ, Chaim Sheba Med Ctr, Sackler Sch Med, Dept Obstet & Gynecol, Tel Aviv, Israel
[3] Hebrew Univ Jerusalem, Heidi Rothberg Sport Med Ctr, Shaare Zedek Med Ctr, Jerusalem, Israel
关键词
ACL injury; athlete triad; athletic performance; female athletes; low energy availability (LEA); oral contraceptives (OCs); relative energy deficiency in sport (RED-S); BONE-MINERAL DENSITY; DEPOT MEDROXYPROGESTERONE ACETATE; RELATIVE ENERGY DEFICIENCY; CRUCIATE LIGAMENT INJURY; LONG-TERM USERS; ORAL-CONTRACEPTIVES; MENSTRUAL-CYCLE; PERFORMANCE; MENSES; AVAILABILITY;
D O I
10.1080/13625187.2023.2287960
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
PurposeOral contraceptives (OCs) are commonly used by female athletes raising concerns regarding the possible adverse effects of OCs on physical performance, musculoskeletal injuries, and bone density. We aimed to review all current studies on the physiological effects of OCs in physically active women.Materials and methodsA review of literature in electronic search in PubMed and Google Scholar databases from December 2002 to December 2022 using relevant keywords. The reference lists of the articles found eligible were also reviewed.ResultsOut of 344 articles in the initial database, 54 clinical studies were eligible for inclusion in our literature review. OCs are used by about two-thirds of female athletes. Current research suggests that OCs' effects on endurance performance and muscle strength are mostly reassuring. OCs do not seem to have a major negative impact on bone health or sports injuries. In fact, new data suggests that they may even significantly reduce the risk of anterior cruciate ligament (ACL) injury.ConclusionsOCs can be safely used by young female athletes, who may also benefit from better menstrual cycle control. OCs offer newly realised protection from ACL injuries. The use of OCs must be carefully individualised according to their preferences, expectations, and experience. Hormonal contraception can be safely prescribed to active women. The International Olympic Committee advocates a new and wider definition for the 'athlete triad', where low energy availability presents a special challenge for these athletes. New data suggests that the use of oral contraceptives may protect against ACL injury.
引用
收藏
页码:8 / 14
页数:7
相关论文
共 50 条
  • [1] Contraception in female athletes
    Goeckenjan, M.
    Gharavi, H.
    [J]. GYNAKOLOGISCHE ENDOKRINOLOGIE, 2021, 19 (03): : 205 - 211
  • [2] Contraception and female athletes
    Goeckenjan, M.
    Platen, P.
    Friedmann-Bette, B.
    Rabe, T.
    [J]. GYNAKOLOGISCHE ENDOKRINOLOGIE, 2010, 8 (04): : 257 - 262
  • [3] Contraception in female athletes
    Rabe, T
    Wolf, A
    Vladescu, E
    Runnebaum, B
    [J]. GEBURTSHILFE UND FRAUENHEILKUNDE, 1998, 58 (09) : M137 - M143
  • [4] Special issues in hormonal contraception
    Segerer, S.
    [J]. GYNAKOLOGE, 2018, 51 (05): : 409 - 420
  • [5] Female athletes: Musculoskeletal concerns
    Ray, T
    [J]. ATHLETIC THERAPY TODAY, 2004, 9 (06): : 44 - 45
  • [6] Female athletes: Medical concerns
    Ray, T
    [J]. ATHLETIC THERAPY TODAY, 2005, 10 (01): : 40 - 41
  • [7] Feeding athletes with special concerns
    Pearson, D
    [J]. STRENGTH AND CONDITIONING JOURNAL, 2003, 25 (03) : 31 - 32
  • [8] An Update on Developments in Female Hormonal Contraception
    Garside, Deborah A.
    Gebril, Ayman
    Nimmo, Natalie
    Alsaadi, Manal
    Mullen, Alexander B.
    Ferro, Valerie A.
    [J]. CURRENT WOMENS HEALTH REVIEWS, 2012, 8 (04) : 276 - 288
  • [9] Recent Developments in Female Hormonal Contraception
    Ferro, Valerie A.
    Mann, Jamie Fs
    [J]. CURRENT WOMENS HEALTH REVIEWS, 2005, 1 (02) : 105 - 118
  • [10] Hormonal contraception and chemoprevention of female cancers
    Pike, MC
    Spicer, DV
    [J]. ENDOCRINE-RELATED CANCER, 2000, 7 (02) : 73 - 83